| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/09/2014 | WO2014005513A1 Cyclopeptide lhrh antagonist derivatives and pharmacal use thereof |
| 01/09/2014 | WO2013151467A3 Method for producing a recombinant peptide and resultant peptide |
| 01/09/2014 | WO2013150127A3 Polymers containing multivalent amyloid-beta-binding d-peptides and their use |
| 01/09/2014 | US20140011979 Stitched polypeptides |
| 01/09/2014 | US20140011734 Cyclic peptides, their preparation and their use as inhibitors of the platelet adhesion |
| 01/09/2014 | US20140011730 Melanocortin Receptor Ligands Modified with Hydantoin |
| 01/09/2014 | US20140010784 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/08/2014 | EP2682401A1 Drug delivery material capable of passing through blood-brain barrier, and peptide and use thereof |
| 01/08/2014 | EP2682400A1 Synthetic apolipoprotein E mimicking polypeptides and methods of use |
| 01/08/2014 | EP2681236A2 Process of preparing guanylate cyclase c agonists |
| 01/08/2014 | EP2681235A1 Hydrogen bond surrogate macrocycles as modulators of ras |
| 01/08/2014 | EP2681226A1 Novel compounds with photoluminescnce properties and applications thereof |
| 01/08/2014 | EP2680883A1 Pcsk9 vaccine |
| 01/08/2014 | EP2680872A2 Compositions and methods for treatment of intracellular damage |
| 01/08/2014 | CN1826354B Methods for preventing and treating alzheimer's disease (AD) |
| 01/08/2014 | CN103502262A Self-assembling hydrogels based on dicephalic peptide amphiphiles |
| 01/08/2014 | CN103502253A Novel compounds with photoluminescnce properties and applications thereof |
| 01/08/2014 | CN103501828A Synthetic vitreous material |
| 01/08/2014 | CN103497237A Alpha-MSH analogue with therapeutic activity |
| 01/08/2014 | CN103497236A Specific heptapeptide targeting to WISP-1 protein and application thereof |
| 01/08/2014 | CN103497235A Small molecular peptide probe and preparation method and application thereof |
| 01/08/2014 | CN103495154A Antagonists of kisspeptin and uses thereof |
| 01/08/2014 | CN103495152A Thymopentin-containing medicine composition, as well as preparation and preparation method thereof |
| 01/08/2014 | CN102731616B Tetanus-toxin-neutralizing B cell epitope peptide and application thereof |
| 01/08/2014 | CN102659929B Transient receptor potential channel-6 (TRPC6) antigen polypeptide and anti-TRPC6 monoclonal antibody |
| 01/08/2014 | CN102477081B Application of novel polypeptide in diagnosis of sjogren's syndrome |
| 01/08/2014 | CN102369281B HLA-A24-binding cancer antigen peptide derived from SOX2 |
| 01/07/2014 | US8623995 Peptide conjugates and fluorescence detection methods for intracellular caspase assay |
| 01/07/2014 | US8623833 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 01/07/2014 | US8623815 TRIM5alpha mutants and uses thereof |
| 01/07/2014 | CA2660424C Sulfonamide compound or salt thereof |
| 01/07/2014 | CA2453967C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/07/2014 | CA2427896C Carrier vectors through an epithelium with tight junctions |
| 01/07/2014 | CA2413141C Peptides with wound healing activity |
| 01/07/2014 | CA2286798C Alpha-o-linked glycoconjugates with clustered(2,6)-st epitopes, methods of preparation and uses thereof |
| 01/03/2014 | WO2014002836A1 Egfr-binding peptide |
| 01/03/2014 | WO2014001822A2 In vitro production of cyclic peptides |
| 01/03/2014 | WO2014001820A1 Japanese cedar peptide for preventing or treating allergy |
| 01/03/2014 | WO2014001229A2 Cell penetrating peptides & methods of identifying cell penetrating peptides |
| 01/02/2014 | US20140005359 Branched chain-containing aromatic compound |
| 01/02/2014 | US20140005358 Natriuretic polypeptides |
| 01/02/2014 | US20140005355 Process for preparation of caspofungin acetate and intermediates |
| 01/02/2014 | US20140005124 Cyclosporin derivatives for treating inflammatory diseases and conditions |
| 01/02/2014 | US20140005118 Beta-catenin targeting peptides and uses thereof |
| 01/02/2014 | US20140005117 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
| 01/02/2014 | US20140005114 Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof |
| 01/02/2014 | US20140005100 Novel cyclosporin derivatives for the treatment and prevention of a viral infection |
| 01/02/2014 | US20140005097 Bioactive peptides and methods of using same |
| 01/02/2014 | US20140004499 Biosurface engineering |
| 01/02/2014 | US20140004137 Immune restricted peptides with increased efficacy |
| 01/02/2014 | US20140004130 MIA (Melanoma Inhibitory Activity) Inhibitors for Detecting, Preventing and Curing Vitiligo |
| 01/02/2014 | US20140004114 Stable and soluble antibodies inhibiting vegf |
| 01/02/2014 | US20140004109 Methods Of Reducing Eosinophil Levels |
| 01/02/2014 | US20140004039 RGD MIMETIC y-AAPEPTIDES AND METHODS OF USE |
| 01/01/2014 | EP2679235A2 Peptides and related molecules that modulate nerve growth factor activity |
| 01/01/2014 | EP2678350A1 A cyclic peptide and conjugate thereof for binding to keratinocytes |
| 01/01/2014 | CN103492409A Methods for manufacturing an antifungal agent |
| 01/01/2014 | CN103491983A Materials and methods relating to cardiovascular imaging |
| 01/01/2014 | CN103484394A Toxic microcystis bacterial strain and purification method of toxins produced by toxic microcystis bacterial strain |
| 01/01/2014 | CN103483447A Broad spectrum monoclonal antibodies or antigen binding fragments thereof of anti-HPV L1 protein, and applications thereof |
| 01/01/2014 | CN103483446A Broad spectrum neutralization monoclonal antibodies or antigen binding fragments thereof of anti-HPV L2 protein, and applications thereof |
| 01/01/2014 | CN103483427A Echinocandin compound purifying method |
| 01/01/2014 | CN103483426A Azacyclohexapeptide preparation method |
| 01/01/2014 | CN103483425A Taro protein extract with itch causing function and preparation method and application thereof |
| 01/01/2014 | CN103483424A Thiopeptide precursor protein, gene encoding it and uses thereof |
| 01/01/2014 | CN103483423A Artificially synthesized signal peptide and application thereof |
| 01/01/2014 | CN103483422A NGR polypeptide radiopharmaceutical as well as preparation method and application thereof |
| 01/01/2014 | CN103483421A Polypeptide used for treating HBV infection and related diseases, and antibodies thereof |
| 01/01/2014 | CN102584953B Purification method for atosiban |
| 01/01/2014 | CN101952432B Peptide, use of the peptide, method for production of the peptide, solid support having the peptide immobilized thereon, and method for production of the solid support |
| 01/01/2014 | CN101553500B GnRH peptide derivative (gonadotropin-releasing hormone) |
| 01/01/2014 | CN101516903B Process for the manufacture of peptides |
| 12/31/2013 | US8618248 Phosphopeptide compositions and anti-phosphopeptide antibody compositions and methods of detecting phosphorylated peptides |
| 12/31/2013 | US8618066 Coating compositions having peptidic antimicrobial additives and antimicrobial additives of other configurations |
| 12/31/2013 | US8618062 Method of modulating integrin mediated cellular activity and agents useful for same |
| 12/31/2013 | US8618046 Treatment of atherosclerosis with cholesterol ester transport protein mimotopes |
| 12/31/2013 | US8617821 Assay method for peptide specific T-cells |
| 12/31/2013 | US8617613 Polymer-based sustained release device |
| 12/31/2013 | US8617560 Peptides for vaccination against human CMV |
| 12/31/2013 | CA2722364C Melanoma antigens |
| 12/27/2013 | WO2013192628A1 Peptoid-peptide hybrids and their use |
| 12/27/2013 | WO2013192430A2 Dynamic biomimetic synzyme catalyst, catalysis, and catalytic systems |
| 12/27/2013 | WO2013192298A1 Apoptosis biomarkers |
| 12/27/2013 | WO2013191166A1 IgE PEPTIDE VACCINE |
| 12/27/2013 | WO2013190148A1 Peptide-silica hybrid materials |
| 12/27/2013 | WO2013190014A1 Improved cd31 peptides |
| 12/27/2013 | WO2013067448A3 Compositions and methods to detect various infectious organisms |
| 12/27/2013 | CA2877301A1 Dynamic biomimetic synzyme catalyst, catalysis, and catalytic systems |
| 12/26/2013 | US20130345395 Synthesis of beta-turn peptidomimetic cyclic compounds |
| 12/26/2013 | US20130345394 Novel npr-b agonists |
| 12/26/2013 | US20130345393 Novel cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method |
| 12/26/2013 | US20130345141 Composition for regulating circadian rhythms, composition for diagnosing circadian rhythm disorders and diagnostic kit |
| 12/26/2013 | US20130345136 Novel npr-b agonists |
| 12/26/2013 | US20130345121 Antibiotic Compositions For The Treatment of Gram Negative Infections |
| 12/26/2013 | US20130345117 Peptide-phospholipid conjugates |
| 12/26/2013 | US20130344592 Factor H Binding Peptides and Uses Thereof |
| 12/26/2013 | US20130344026 Dimeric Smac Mimetics |
| 12/26/2013 | US20130343989 Methods and Compositions Related to Internalizing RGD Peptides |
| 12/25/2013 | EP2676683A1 Material for tissue regeneration, aqueous protein solution containing same, and method for gelling same |
| 12/25/2013 | EP2675825A1 Novel activator peptides for synthesizing extracellular matrix proteins, and cosmetic compositions including same |